Signaling pathways
-
BA5907 SudoxicamSummary: Sudoxicam is a reversible, orally active antagonist of the enol-carboxamide class of nonsteroidal anti-inflammatory drugs (NSAIDs). - BA5908 TepoxalinSummary: Tepoxalin is a dual inhibitor of cyclooxygenase (COX) and 5-lipoxygenase (5-LO).
- BA5909 MacelignanSummary: Macelignan ((+)-Anwulignan; Anwuligan) is a bioactive lignan isolated from nutmeg.
-
BA5910 LoxoprofenSummary: Loxoprofen is an orally active and antipyretic nonsteroidal anti-inflammatory drug studied for pain relief. - BA5911 HexahydrocurcuminSummary: Hexahydrocurcumin, one of the major metabolites of curcumin, is a selective inhibitor of oral activity.
- BA5913 TFAPSummary: TFAP is a selective inhibitor of cyclooxygenase 1.
- BA5914 CP-74006Summary: A selective inhibitor.
-
BA5915 PolmacoxibSummary: Polmacoxib (CG100649) is a first-of-its-kind, orally active nonsteroidal anti-inflammatory drug (NSAID) that is a dual inhibitor. - BA5916 SphondinSummary: Inhibitory effect on IL-1β-induced elevation of protein and PGE release levels in A549 cells.
- BA5917 EnflicoxibSummary: Enflicoxib (E6087) is a nonsteroidal anti-inflammatory compound that selectively inhibits cyclooxygenase 2.